CRSP stock news
This page provides real-time market news, earnings updates, and company announcements related to CRISPR Therapeutics AG (CRSP).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-13 08:23 EST
ARK's technology investments steer through hurdles in regulation and profitability
Bitget-RWA2025-11-19 13:20:15
MAHA's Struggle with Identity: Corporate Connections Versus Community Origins
Bitget-RWA2025-11-23 11:24:22
The 9 top biotech startups from Disrupt Startup Battlefield
TechCrunch2025-12-24 16:09:17
Intellia gets FDA nod to resume gene therapy trial after safety pause
101 finance2026-01-27 13:39:10
Caribou Biosciences to Participate in Upcoming Investor Conferences
Finviz2026-02-12 21:09:37
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-02-12 21:33:42
CRISPR Therapeutics AG (CRSP) Reports Q4 Loss, Lags Revenue Estimates
Finviz2026-02-13 00:03:31
Caribou Biosciences to Participate in Upcoming Investor Conferences
Finviz2026-02-12 21:09:37
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-02-12 21:33:42
CRISPR Therapeutics AG (CRSP) Reports Q4 Loss, Lags Revenue Estimates
Finviz2026-02-13 00:03:31
CRSP stock chart
CRSP stock detailsCRSP stock price change
On the last trading day, CRSP stock closed at 48.43 USD, with a price change of 0.23% for the day.
Trade stock futuresAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more